Merck & Co. Inc. (MRK)

$ 129.56
   
  • Change Today:
    $4.19
  • 52 Week High: $129.61
  • 52 Week Low: $77.60
  • Currency: US Dollars
  • Shares Issued: 2,474.63m
  • Volume: 7,833,991
  • Market Cap: $320,613m
  • RiskGrade: 92

Deal with Barclays    Trade now with Barclays Stockbrokers

Merck Overview

US drugmaker, Merck & Co, is a leading global research-driven pharmaceutical products and services company. The company discovers, develops, manufactures and markets a broad range of innovative products to improve human and animal health, directly and through its joint ventures. Its products, generally sold by prescription, include therapeutic and preventive agents for the treatment of human disorders and animal health supplies. The company’s products are sold, primarily, to drug wholesalers and retailers, hospitals, clinics, government agencies and managed healthcare providers, such as health maintenance organisations and other institutions.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Merck Financials

Latest F'cast
Div Yield 2.6%
Div Cover 2.2
Op Mrgn 32.4%
ROCE 39.2%
Latest F'cast
P/E 17.2
PEG 2.2
Pr/Revenue 4.8
Pr/Book 5.9
Latest F'cast
Revenue 1.3%
PBT 5.7%
EPS 8.0%
DPS 5.1%

Merck Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 48,704.00 13,879.00 488.00¢ 15.7 0.1 +173% 264.00¢ 3.4%
31-Dec-22 59,283.00 16,444.00 573.00¢ 19.4 1.1 +17% 280.00¢ 2.5%
31-Dec-23 60,115.00 1,889.00 14.00¢ 778.7 n/a -98% 296.00¢ 2.7%
31-Dec-24 64,168.00 19,936.00 676.00¢ 14.7 0.0 +4,729% 312.00¢ 3.1%
31-Dec-25 65,011.00 21,067.00 730.00¢ 14.4 1.8 +8% 328.00¢ 3.1%

Merck ShareCast News

Shares jump as Merck lifts full-year guidance 13-May-2026 ShareCast
Merck beats Q1 forecasts on strong Keytruda demand 30-Apr-2026 ShareCast
Merck to buy Terns Pharmaceuticals for $6.7bn 25-Mar-2026 ShareCast

Merck Top Newspaper Links

Merck increases antibiotic offering with $9.5bn ... 09-Dec-2014 Telegraph
Reckitt Benckiser bows out of race for Merck's c... 01-May-2014 Telegraph
Patents Ending, Eli Lilly Chases New Drugs 01-Oct-2010 New York Times

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Merck Market Data

Currency US Dollars
Share Price $ 129.56
Change Today $ 4.19
% Change 3.34 %
52 Week High $129.61
52 Week Low $77.60
Volume 7,833,991
Shares Issued 2,474.63m
Market Cap $320,613m
RiskGrade 92

Trades for 02-Jul-2026

Time Volume / Share Price
16:03 1,661,935 @ $129.56
16:00 5,943 @ $129.52
16:00 2,031 @ $129.52
16:00 1,544 @ $129.52
16:00 400 @ $129.52

Top of Page